Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Ozenoxacin reduces sebum production, helping manage acne.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

Minoxidil can reduce functions related to androgen receptors.

Berberine may reduce prostate enlargement by blocking inflammation.

Different substances affect hair and skin cell growth in various ways.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Phyllanthus urinaria extract may help treat hair loss by blocking a hair-related enzyme.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.